JP2007524627A5 - - Google Patents

Download PDF

Info

Publication number
JP2007524627A5
JP2007524627A5 JP2006517617A JP2006517617A JP2007524627A5 JP 2007524627 A5 JP2007524627 A5 JP 2007524627A5 JP 2006517617 A JP2006517617 A JP 2006517617A JP 2006517617 A JP2006517617 A JP 2006517617A JP 2007524627 A5 JP2007524627 A5 JP 2007524627A5
Authority
JP
Japan
Prior art keywords
day
formula
compound
group
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006517617A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007524627A (ja
JP5583882B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2004/020277 external-priority patent/WO2005000245A2/en
Publication of JP2007524627A publication Critical patent/JP2007524627A/ja
Publication of JP2007524627A5 publication Critical patent/JP2007524627A5/ja
Application granted granted Critical
Publication of JP5583882B2 publication Critical patent/JP5583882B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2006517617A 2003-06-23 2004-06-23 テロメラーゼ活性を増大させるための組成物および方法 Expired - Lifetime JP5583882B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US48098803P 2003-06-23 2003-06-23
US60/480,988 2003-06-23
PCT/US2004/020277 WO2005000245A2 (en) 2003-06-23 2004-06-23 Compositions and methods for increasing telomerase activity

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2011035191A Division JP5841337B2 (ja) 2003-06-23 2011-02-21 テロメラーゼ活性を増大させるための組成物および方法

Publications (3)

Publication Number Publication Date
JP2007524627A JP2007524627A (ja) 2007-08-30
JP2007524627A5 true JP2007524627A5 (enExample) 2009-02-05
JP5583882B2 JP5583882B2 (ja) 2014-09-03

Family

ID=33551962

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2006517617A Expired - Lifetime JP5583882B2 (ja) 2003-06-23 2004-06-23 テロメラーゼ活性を増大させるための組成物および方法
JP2011035191A Expired - Lifetime JP5841337B2 (ja) 2003-06-23 2011-02-21 テロメラーゼ活性を増大させるための組成物および方法
JP2013219989A Expired - Fee Related JP5913253B2 (ja) 2003-06-23 2013-10-23 テロメラーゼ活性を増大させるための組成物および方法
JP2016000130A Withdrawn JP2016041770A (ja) 2003-06-23 2016-01-04 テロメラーゼ活性を増大させるための組成物および方法

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2011035191A Expired - Lifetime JP5841337B2 (ja) 2003-06-23 2011-02-21 テロメラーゼ活性を増大させるための組成物および方法
JP2013219989A Expired - Fee Related JP5913253B2 (ja) 2003-06-23 2013-10-23 テロメラーゼ活性を増大させるための組成物および方法
JP2016000130A Withdrawn JP2016041770A (ja) 2003-06-23 2016-01-04 テロメラーゼ活性を増大させるための組成物および方法

Country Status (24)

Country Link
US (3) US7846904B2 (enExample)
EP (2) EP2548880B1 (enExample)
JP (4) JP5583882B2 (enExample)
KR (3) KR20110089887A (enExample)
CN (1) CN1809364B (enExample)
AP (1) AP2280A (enExample)
AU (2) AU2004251753C1 (enExample)
BR (1) BRPI0411856A (enExample)
CA (1) CA2528483C (enExample)
CY (2) CY1119951T1 (enExample)
DK (2) DK2548880T3 (enExample)
EA (1) EA009442B1 (enExample)
ES (2) ES2666864T3 (enExample)
HR (2) HRP20180330T1 (enExample)
HU (2) HUE036559T2 (enExample)
LT (2) LT2548880T (enExample)
MX (1) MXPA05013844A (enExample)
NZ (1) NZ544191A (enExample)
PL (2) PL2548880T3 (enExample)
PT (2) PT2548880T (enExample)
SI (2) SI1644009T1 (enExample)
TR (2) TR201802543T4 (enExample)
WO (1) WO2005000245A2 (enExample)
ZA (1) ZA200509846B (enExample)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7585622B1 (en) 1996-10-01 2009-09-08 Geron Corporation Increasing the proliferative capacity of cells using telomerase reverse transcriptase
US6337200B1 (en) 1998-03-31 2002-01-08 Geron Corporation Human telomerase catalytic subunit variants
NZ544191A (en) 2003-06-23 2008-12-24 Geron Corp Compositions and methods for increasing telomerase activity
US9248088B2 (en) * 2003-06-25 2016-02-02 Telomerase Activation Sciences, Inc. Compositions and methods for skin conditioning
EP1876893B1 (en) 2005-04-15 2012-04-11 Geron Corporation Cancer treatment by combined inhibition of proteasome and telomerase activities
US8197860B2 (en) * 2005-06-23 2012-06-12 Nuliv Holding Inc. Method for enhancing nutrient absorption with astragalosides
CN100333731C (zh) * 2005-09-08 2007-08-29 南京医科大学 黄芪甲苷在制备治疗糖尿病周围神经病变药物中的应用
CN100384830C (zh) * 2006-01-12 2008-04-30 天津药物研究院 环黄芪醇类衍生物以及用途
US7992749B2 (en) 2006-03-30 2011-08-09 Nike, Inc. Support element for a carry strap
EP2101789B1 (en) 2006-10-30 2014-12-31 Geron Corporation Combined telomerase inhibitor and gemcitabine for the treatment of cancer
EA201401193A1 (ru) * 2007-06-04 2015-08-31 Бен-Гурион Юниверсити Оф Дзе Негев Рисерч Энд Дивелопмент Оторити Триарильные соединения и композиции, их содержащие
CN101225424B (zh) * 2007-09-13 2013-05-29 天津药物研究院 环黄芪醇的单葡萄糖苷、其制备方法、药物组合物和应用
US8168596B2 (en) * 2008-10-17 2012-05-01 Nuliv Holding Inc. Use of cycloartane compounds for treating arthritis
HRP20161324T1 (hr) * 2009-05-18 2016-11-18 Telomerase Activation Sciences, Inc. Pripravci i postupci za povećavanje telomerazne aktivnosti
WO2014186603A1 (en) * 2013-05-15 2014-11-20 Fybrands Corp. Compositions for improving the hair, skin, and nails
CN106061940A (zh) 2013-11-05 2016-10-26 本古里安大学内盖夫研究发展局 治疗糖尿病和由其引发的并发疾病的化合物
CN104491185A (zh) * 2014-12-06 2015-04-08 郭亮 一种祛风湿药酒及其制备方法
CN104435371A (zh) * 2014-12-06 2015-03-25 郭亮 一种用于治疗关节炎的药酒
CN104435370A (zh) * 2014-12-06 2015-03-25 王香平 风湿保健酒
KR20160069857A (ko) 2014-12-09 2016-06-17 (주)스피어테크 텔로미어 활성을 증가시키기 위한 조성물 및 그 조성물의 제조방법
CN104817610A (zh) * 2015-03-15 2015-08-05 北京化工大学 利用硫酸水解制备环黄芪醇的方法
AU2016243750B2 (en) 2015-04-03 2022-02-03 Propagenix Inc. Ex vivo proliferation of epithelial cells
US10100285B2 (en) 2015-04-03 2018-10-16 Propagenix Inc. Ex vivo proliferation of epithelial cells
CN106474094A (zh) * 2015-08-31 2017-03-08 南京理工大学 一种环黄芪醇电纺纤维膜及其制备方法
JP6869231B2 (ja) 2015-09-11 2021-05-12 プロパジェニクス インコーポレイテッド ex vivoでの上皮細胞の増殖
CN106307522A (zh) * 2016-11-06 2017-01-11 谭淞文 一种抗衰老保健品及其制备方法和食用方法
CN106831927B (zh) * 2017-02-07 2018-02-09 江西师范大学 一种黄芪甲苷的合成方法
CN108498521B (zh) * 2017-02-24 2020-05-05 北京大学 环黄芪醇在制备抑制腹主动脉瘤的药物中的应用
US10098922B1 (en) 2017-11-30 2018-10-16 Optigenex, Inc. Increasing telomere length in a cell
WO2020028055A1 (en) * 2018-07-31 2020-02-06 ADLER, Benjamin, Aaron Ophthalmic formulations and uses thereof
KR102655940B1 (ko) 2018-08-13 2024-04-11 (주)아모레퍼시픽 신규 진세노사이드, 및 이를 포함하는 항염 조성물
US11000537B2 (en) 2018-10-17 2021-05-11 Amorepacific Corporation Composition comprising novel ginsenoside
KR102635196B1 (ko) 2018-10-17 2024-02-13 (주)아모레퍼시픽 신규 진세노사이드를 포함하는 미백 조성물
US11000538B2 (en) 2018-10-31 2021-05-11 Amorepacific Corporation Composition for enhancing exercise ability or anti-fatigue comprising novel ginsenoside
WO2020131058A1 (en) * 2018-12-20 2020-06-25 Muhammed Majeed Telomerase enhancement potential of ecdysterone
CN109942663B (zh) * 2019-04-22 2021-10-26 中国人民解放军联勤保障部队第九八九医院 利用双相酸水解制备环黄芪醇的方法
MX2019006749A (es) 2019-06-10 2022-11-28 Univ Mexico Nac Autonoma Compuestos activadores de senescencia celular.
KR102842908B1 (ko) 2019-09-27 2025-08-07 (주)아모레퍼시픽 신규 진세노사이드를 포함하는 피부 탄력 개선용 조성물
KR102842907B1 (ko) 2019-09-27 2025-08-07 (주)아모레퍼시픽 신규 진세노사이드를 포함하는 갱년기 증상의 예방 또는 개선용 조성물
CN111419854B (zh) * 2020-05-18 2021-03-30 南通大学 具有特殊七元环结构的三萜在制备预防和治疗神经损伤药物中的应用
US12305233B1 (en) 2020-07-09 2025-05-20 Arizona Board Of Regents On Behalf Of Arizona Ultra-high-throughput assay for telomerase repeat addition processivity
CN113480628B (zh) * 2021-08-17 2022-06-21 贵州师范大学 一种贵州疣螈多肽tk-cath及其编码基因和应用
CN113968894B (zh) * 2021-11-05 2024-05-28 山西大学 一种用黄芪甲苷降解制备环黄芪醇的方法
KR102666469B1 (ko) * 2023-05-04 2024-05-17 주식회사 아리바이오 텔로머라제 활성화제와 나노 입자를 포함하는 약물 전달용 조성물 및 이를 포함하는 탈모 예방, 개선 또는 치료용 조성물
CN119818509B (zh) * 2025-02-10 2025-10-17 山西中医药大学 黄芪醇在制备治疗或缓解帕金森病的产品中的应用
CN120137936A (zh) * 2025-03-14 2025-06-13 北京娅熙妍国际贸易有限公司 端粒酶变体及其在抗衰老中的应用

Family Cites Families (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6212792A (ja) * 1986-07-18 1987-01-21 Osaka Chem Lab オウギサポニン類の単離法
JPS6212791A (ja) * 1986-07-18 1987-01-21 Osaka Chem Lab オウギサポニン、その単離法およびその用途
IT1259645B (it) 1992-04-10 1996-03-25 Solis Srl Metodo per la rivelazione della variazione di densita' di un tessuto e dispositivo per la sua attuazione
US6007989A (en) 1992-05-13 1999-12-28 Board Of Regents, The University Of Texas System Methods of screening for compounds that derepress or increase telomerase activity
US5629154A (en) 1993-11-12 1997-05-13 Geron Corporation Telomerase activity assays
FR2695561B1 (fr) 1992-09-17 1994-12-02 Lvmh Rech Gie Composition cosmétique ou dermatologique contenant au moins une saponine de type ginsenoside, et ses applications, notamment pour le soin des cheveux.
US5863726A (en) 1993-11-12 1999-01-26 Geron Corporation Telomerase activity assays
JPH07238026A (ja) * 1994-02-25 1995-09-12 Pola Chem Ind Inc 動脈硬化抑制剤及びこれを含む食品又は医薬
AT402890B (de) 1994-03-16 1997-09-25 Berbi Gmbh Verwendung von notoginsenosid r1 zur herstellung von arzneimitteln
US5583016A (en) 1994-07-07 1996-12-10 Geron Corporation Mammalian telomerase
DK0778842T3 (da) * 1994-07-07 2006-03-20 Geron Corp Mammal telomerase
US6162459A (en) 1995-02-24 2000-12-19 National Science Council Acyclovir transdermal delivery system
AUPN411195A0 (en) 1995-07-10 1995-08-03 Cathay Herbal Laboratories Pty Ltd Medicinal composition
CN1079265C (zh) 1995-08-01 2002-02-20 裴国增 灵芝口服液及其配制方法
US5785977A (en) 1996-02-07 1998-07-28 Breithbarth; Richard Non-metallic microparticle carrier materials
US5916565A (en) 1996-03-08 1999-06-29 In Clover, Inc. Product and method for treating joint disorders in vertebrates
TW452494B (en) 1996-03-12 2001-09-01 Jang De Shan Herbal composition for stimulating blood circulation
US5900226A (en) 1997-04-09 1999-05-04 Uop Llc Drying agents for non-foamed polyurethanes
JPH1036388A (ja) * 1996-07-25 1998-02-10 Kureha Chem Ind Co Ltd ジンセノサイド類含有hsp47合成抑制剤
US6261836B1 (en) 1996-10-01 2001-07-17 Geron Corporation Telomerase
NZ334709A (en) 1996-10-01 2001-06-29 Univ Technology Corp Detection of hTRT activity or expression and use in the treatment of cancer
US6093809A (en) 1996-10-01 2000-07-25 University Technology Corporation Telomerase
NZ336869A (en) 1997-01-28 2001-01-26 Graeme A Close Pharmaceutical compositions comprising aqueous alcoholic Centipeda plant extracts
US5786343A (en) 1997-03-05 1998-07-28 Immudyne, Inc. Phagocytosis activator compositions and their use
BR9811758A (pt) 1997-09-05 2000-08-29 Procter & Gamble Produto de limpeza e condicionamento para tratamento pessoal de utilização única, descartável e processos para manufaturar, para distribuir e para limpar e condicionar a pele com esse produto
ES2186199T3 (es) 1997-09-12 2003-05-01 Procter & Gamble Articulo de limpieza y acondicionador para la piel o el pelo.
JP2002500040A (ja) 1998-01-12 2002-01-08 コールド スプリング ハーバー ラボラトリー 細胞の寿命の延長、方法および試薬
GB9815177D0 (en) 1998-07-13 1998-09-09 King S College London Treatment of skin disorders
WO2000008135A1 (en) 1998-08-09 2000-02-17 Board Of Regents, The University Of Texas System Methods and compositions for inhibiting or stimulating telomerase assembly
CA2352486A1 (en) 1998-11-25 2000-06-02 Genetica, Inc. Methods and reagents for increasing proliferative capacity and preventing replicative senescence
JP2000204091A (ja) * 1999-01-13 2000-07-25 Nippon Suisan Kaisha Ltd 新規ベンゾジオキソ―ル誘導体
JP2000229827A (ja) * 1999-02-05 2000-08-22 Kose Corp 皮膚外用剤
JP2000229834A (ja) * 1999-02-10 2000-08-22 Kanebo Ltd 化粧料
AUPQ127399A0 (en) * 1999-06-29 1999-07-22 Guangzhou University Of Traditional Chinese Medicine Compositions and methods for treating or preventing osteoporosis
KR100858465B1 (ko) 1999-09-10 2008-09-16 제론 코포레이션 올리고뉴클레오티드 엔3'→피5' 티오포스포라미데이트,이의 합성 및 용도
JP2001258505A (ja) * 2000-03-24 2001-09-25 Fancl Corp 食品組成物
CA2307393A1 (en) * 2000-05-01 2001-11-01 The University Of British Columbia Ginsenoside chemotherapy
US6277396B1 (en) 2000-05-11 2001-08-21 Maximum Human Performance, Inc. Dietary supplement containing a thermogenic substance and an adrenal support substance
EP1295893A4 (en) 2000-05-31 2005-10-26 Japan Science & Tech Agency REGENERATION PROMOTERS OF CUTANE TISSUE CONTAINING GINSENOSIDE RB1
CN1172677C (zh) * 2000-07-14 2004-10-27 复旦大学附属中山医院 黄芪甲苷在制备药物组合物中的应用
GB0105613D0 (en) 2001-03-07 2001-04-25 Univ Cambridge Tech Pharmaceutically effective compounds and their use
WO2002007732A2 (en) 2000-07-26 2002-01-31 Cambridge University Technical Services Limited Use of panaxatriol for stimulation angiogenesis
US6696094B2 (en) 2000-10-18 2004-02-24 Tzu-Sheng Wu Herbal pharmaceutical composition for treatment of HIV/AIDS patients
CN1242807C (zh) * 2000-11-08 2006-02-22 天津市延龄营养保健品有限公司 一种抗皮肤过敏的药物组合物及其制法和用途
CN1369276A (zh) * 2001-02-12 2002-09-18 徐秀荣 有效减轻体重的组合物和方法
JP2002275086A (ja) * 2001-03-15 2002-09-25 Fancl Corp 虚弱体質改善用組成物
WO2002091999A2 (en) 2001-05-09 2002-11-21 Geron Corporation Treatment for wounds
US20020182272A1 (en) 2001-05-30 2002-12-05 Bruce Halstead Methods of treatment of HIV-associated conditions
JP2003089687A (ja) * 2001-07-03 2003-03-28 Tanabe Seiyaku Co Ltd 新規ブタジエン誘導体、その製法およびその合成中間体
US20040180938A1 (en) 2001-07-03 2004-09-16 Akio Ohtani Novel butadiene derivatives, process for preparation of the same and intermediates for the synthesis thereof
US6855344B2 (en) 2001-07-17 2005-02-15 Integrated Chinese Medicine Holdings, Ltd. Compositions and methods for prostate and kidney health and disorders, an herbal preparation
US20030108629A1 (en) 2001-07-17 2003-06-12 Chou Wen Hsien Compositions and methods for prostate and kidney health and disorders, an herbal preparation
CN1164608C (zh) * 2001-08-31 2004-09-01 上海中医药大学 具有抗心肌纤维化作用的黄芪皂甙甲
CN1406585A (zh) 2001-09-07 2003-04-02 中国科学院上海药物研究所 一种治疗病毒性心肌炎的药物组合物
JP2003160497A (ja) * 2001-11-22 2003-06-03 Toshin Kagaku Kk 皮膚外用剤
US20070042962A1 (en) 2002-02-04 2007-02-22 Adams David S Peptide dependent upregulation of telomerase expression
CN1236803C (zh) 2002-03-20 2006-01-18 郑国芃 一种治疗风湿症的中药
CN1189176C (zh) * 2002-07-22 2005-02-16 江苏正大天晴药业股份有限公司 黄芪甲甙组合物及其制备方法
AU2003228378A1 (en) * 2003-03-26 2004-11-23 Westlake Partners Herbal compositions and methods for effecting weight loss in humans
US20070259014A1 (en) * 2003-06-20 2007-11-08 Vgx Pharmaceuticals, Inc. Compositions for and Methods for Treating Hiv
NZ544191A (en) * 2003-06-23 2008-12-24 Geron Corp Compositions and methods for increasing telomerase activity
US9248088B2 (en) 2003-06-25 2016-02-02 Telomerase Activation Sciences, Inc. Compositions and methods for skin conditioning
US20070122501A1 (en) 2003-06-27 2007-05-31 Hong Kong University Of Science And Technology Formulations containing astragalus extracts and uses thereof

Similar Documents

Publication Publication Date Title
JP2007524627A5 (enExample)
Cintra et al. Multiple apical periodontitis influences serum levels of cytokines and nitric oxide
EA022314B1 (ru) Способ лечения псориаза
JP2001520994A (ja) 消化管疾患を治療するためにクマリン誘導体を用いる用途
RS102304A (sr) Preparati za terapeutsku primenu koji sadrže vitamin, so metala i insulin ili hormon rasta
JP2007508371A (ja) 軟骨再生剤としてアピゲニンを含有する骨関節炎治療組成物
CA2794581C (en) Method of treating osteoporosis
KR101072175B1 (ko) 데커신 및/또는 데커시놀 안젤레이트, 또는 데커신및/또는 데커시놀 안젤레이트를 유효성분으로 하는당귀추출물을 포함하는 배뇨장애 치료제 및 부종 치료제조성물
TWI435727B (zh) 調節細胞激素分泌之用途
CN116270695A (zh) 一种预防或治疗代谢相关脂肪性肝病的药物组合物
US20080262071A1 (en) Pindolol for the Treating Premenstrual Syndrome and Premenstrual Dysphoric Disorder
EP0087744B1 (en) Lipid metabolism improving agents
KR20090075269A (ko) 비만 예방 및 치료용 조성물
CN1218697C (zh) 用于治疗或改善关节炎的药物组合物和饮食补充剂
EP4021430A1 (en) Treatment of obesity and related conditions
EP2025340A1 (en) Plant extracts for the treatment of rheumatoid arthritis
KR102868871B1 (ko) 니코틴아미드, 포도추출물, 케르세틴 및 l-트립토판을 포함하는 nad+ 생성 증진용 기능성 식품 조성물
JPH06340528A (ja) ナフタレン誘導体を有効成分とする骨疾患の予防及び治療剤
Barbu et al. The effect of chronic viral hepatitis B and C on bone mineral density
WO2006030306A2 (en) Pindolol for treating premenstrual syndrome and premenstrual dysphoric disorder
JP2001335503A (ja) ラジカル消去用医薬品
CH718709A2 (de) Verwendung von Cumarin-Derivaten zur Behandlung von Verdauungstrakt-Erkrankungen.
CN107308175A (zh) 女贞苷作为CaSR拮抗剂的用途
CN1305493C (zh) 一种治疗脑中风的中药有效部位及其分离制备方法
CN120078796A (zh) 一种用于阿尔茨海默病的治疗药剂及其应用